Prescription drug · ANDA
Tasimelteon NDC 69238-2548
Tasimelteon 20 mg/1 · Capsule · Oral · Amneal Pharmaceuticals NY LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 69238-2548-3 | 69238254803 | 30 CAPSULE in 1 BOTTLE (69238-2548-3)Marketed from Feb 24, 2023 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Tasimelteon
- Generic name (nonproprietary)
- tasimelteon
- Active ingredients
- Tasimelteon — 20 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- Amneal Pharmaceuticals NY LLCNDC labeler code 69238
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 211654
- Marketing start
- Listing expires
- Other FDA classes
- Melatonin Receptor Agonists (Mechanism)
- Identifiers
- Product ID 69238-2548_071804f4-9647-4a4d-a394-55b9e976dc9fSPL ID 071804f4-9647-4a4d-a394-55b9e976dc9fSPL set ID 99cb1928-e57d-4d04-87a1-38108780598aRxCUI 1490473UNII SHS4PU80D9UPC 0369238254839
- Pharmacologic class
- Melatonin Receptor Agonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N469238254803followed by a unit qualifier and the quantityPackage 69238-2548-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Tasimelteon capsule is a melatonin receptor agonist. Tasimelteon capsules are indicated for the treatment of Non 24-Hour Sleep-Wake Disorder (Non-24) in adults ( 1 ) 1.1 Non-24-Hour Sleep-Wake Disorder (Non-24) Tasimelteon capsules are indicated for the treatment of Non-24-Hour in adults.
Excerpt only. Read the full label for complete information.
About NDC 69238-2548
- What is NDC 69238-2548?
- 69238-2548 is the product NDC for Tasimelteon, Tasimelteon 20 mg/1 capsule, listed with the FDA by Amneal Pharmaceuticals NY LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Tasimelteon.
- What is the active ingredient?
- Tasimelteon.
- Who is the labeler?
- Amneal Pharmaceuticals NY LLC, NDC labeler code 69238. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Tasimelteon?
- 1 other product NDC are listed under this name. See all Tasimelteon NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Tasimelteon products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Tasimelteon | Tasimelteon 20 mg/1 | CapsuleOral | Apotex Corp. | 60505-4665 | 60505-4665-0360505-4665-09 |